Slow self-activation enhances the potency of viridin prodrugs
- PMID: 18630894
- PMCID: PMC2663427
- DOI: 10.1021/jm800374f
Slow self-activation enhances the potency of viridin prodrugs
Abstract
When the viridin wortmannin (Wm) is modified by reaction with certain nucleophiles at the C20 position, the compounds obtained exhibit an improved antiproliferative activity even though a covalent reaction between C20 and a lysine in the active site of PI3 kinase is essential to Wm's ability to inhibit this enzyme. Here we show that this improved potency results from an intramolecular attack by the C6 hydroxyl group that slowly converts these inactive prodrugs to the active species Wm over the 48 h duration of the antiproliferative assay. Our results provide a guide for selecting Wm-like compounds to maximize kinase inhibition with the variety of protocols used to assess the role of PI3 kinase in biological systems, or for achieving optimal therapeutic effects in vivo . In addition, the slow self-activation of WmC20 derivatives provides a mechanism that can be exploited to obtain kinase inhibitors endowed with physical and pharmacokinetic properties far different from man-made kinase inhibitors because they do not bind to kinase active sites.
Figures





Similar articles
-
Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin.Org Biomol Chem. 2004 Jul 7;2(13):1911-20. doi: 10.1039/b405431h. Epub 2004 Jun 14. Org Biomol Chem. 2004. PMID: 15227545
-
A stabilized demethoxyviridin derivative inhibits PI3 kinase.Bioorg Med Chem Lett. 2009 Aug 1;19(15):4223-7. doi: 10.1016/j.bmcl.2009.05.105. Epub 2009 May 30. Bioorg Med Chem Lett. 2009. PMID: 19523825 Free PMC article.
-
Viridin analogs derived from steroidal building blocks.Bioorg Med Chem Lett. 2012 Nov 15;22(22):6919-22. doi: 10.1016/j.bmcl.2012.09.015. Epub 2012 Sep 13. Bioorg Med Chem Lett. 2012. PMID: 23040731
-
The viridin family of steroidal antibiotics.Nat Prod Rep. 1995 Aug;12(4):381-4. doi: 10.1039/np9951200381. Nat Prod Rep. 1995. PMID: 7666979 Review. No abstract available.
-
The Taxonomy of Covalent Inhibitors.Biochemistry. 2018 Jun 19;57(24):3326-3337. doi: 10.1021/acs.biochem.8b00315. Epub 2018 Apr 30. Biochemistry. 2018. PMID: 29689165 Free PMC article. Review.
Cited by
-
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation.J Clin Invest. 2008 Dec;118(12):4058-66. doi: 10.1172/JCI36335. Epub 2008 Nov 6. J Clin Invest. 2008. PMID: 19033674 Free PMC article.
-
The PI3K pathway as drug target in human cancer.J Clin Oncol. 2010 Feb 20;28(6):1075-83. doi: 10.1200/JCO.2009.25.3641. Epub 2010 Jan 19. J Clin Oncol. 2010. PMID: 20085938 Free PMC article. Review.
-
Theranostic Imaging of the Kinases and Proteases that Modulate Cell Death and Survival.Theranostics. 2012;2(2):148-55. doi: 10.7150/thno.4077. Epub 2012 Feb 8. Theranostics. 2012. PMID: 22400062 Free PMC article.
-
Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function.Arthritis Rheum. 2009 Aug;60(8):2314-24. doi: 10.1002/art.24704. Arthritis Rheum. 2009. PMID: 19644878 Free PMC article.
-
The antiproliferative cytostatic effects of a self-activating viridin prodrug.Mol Cancer Ther. 2009 Jun;8(6):1666-75. doi: 10.1158/1535-7163.MCT-08-1012. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509266 Free PMC article.
References
-
- Wipf P, Halter Robert J. Chemistry and biology of wortmannin. Organic & biomolecular chemistry. 2005;3:2053–61. - PubMed
-
- Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, et al. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994;54:2419–23. - PubMed
-
- Creemer LC, Kirst HA, Vlahos CJ, Schultz RM. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase. J Med Chem. 1996;39:5021–4. - PubMed
-
- Liu Y, Shreder KR, Gai W, Corral S, Ferris DK, Rosenblum JS. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. Chem Biol. 2005;12:99–107. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Chemical Information